488-489 / 2351
Influence of p16/HPV on radiotherapy outcome in HNSCC
(5fx/week)
Disease‐specific survival
DAHANCA 5 (N=156)
Loco‐regional tumour control
0.36 (0.20 ‐ 0.64)
Overall survival
0.35 (0.19 ‐ 0.64)
0.44 (0.28 ‐ 0.68)
Lassen et al. JCO 27:1992‐98,2009